Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

CUSIP: 19249H103

Q2 2020 13F Holders as of 30 Jun 2020

Holder snapshot 7 signals
Share change
+12,210,490
Put/Call ratio
104%
SEC-reported price per share
$17.86
Number of holders
187
Value change
+$228,840,811
Number of buys
113
Open additional details 1 more signal available
Number of sells
97
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
153,624,096

Security key

19249H103

Report period

Q2 2020

Institutions

187

Top holders

10

Ownership snapshot

Top reported holders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Temasek Holdings (Private...
Disclosed value leader
Temasek Holdings (Private...
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F Lead comparable stake: 4.8% Showing 1-6 of 15 holder rows.

Quick read

Temasek Holdings (Private) Ltd leads the comparable SEC ownership view at 4.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Temasek Holdings (Private) Ltd's linked filing trail.
Comparable ownership Top 5
Temasek Holdings (Private) Ltd 4.8%
BlackRock Finance, Inc. 3.5%
JPMORGAN CHASE & CO 2.7%
STATE STREET CORP 2.3%
AMERIPRISE FINANCIAL INC 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Temasek Holdings (Private) Ltd
13F
Company
13F
4.8%
$119,722,000
7,381,116 shares
31 Mar 2020
BlackRock Finance, Inc.
13F
Company
13F
3.5%
$88,442,000
5,452,560 shares
31 Mar 2020
JPMORGAN CHASE & CO
13F
Company
13F
2.7%
$66,896,000
4,124,245 shares
31 Mar 2020
STATE STREET CORP
13F
Company
13F
2.3%
$56,819,000
3,502,994 shares
31 Mar 2020
AMERIPRISE FINANCIAL INC
13F
Company
13F
2.2%
$55,768,000
3,438,334 shares
31 Mar 2020
ALLIANCEBERNSTEIN L.P.
13F
Company
13F
2.1%
$52,331,000
3,226,324 shares
31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
187
Shares
86,666,598
Rows available
187
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
185
Q2 2020 holders
187
Holder diff
2
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .